MiGo Tracker Remote Monitoring of Home Exercise After Stroke
MiGo Tracker: Seamless Remote Therapeutic Monitoring of Exercise Adherence After Stroke
Flint Rehabilitation Devices, LLC
50 participants
Jun 11, 2025
INTERVENTIONAL
Conditions
Summary
This project will determine the safety and effectiveness of a MiGo Tracker RTM program in a randomized controlled trial with individuals with subacute stroke (N=50). Participants will be randomly assigned to either the MiGo Tracker RTM program (intervention group) or prescription of home exercises with no monitoring (usual care/control group). All participants will still receive usual post-stroke care, including outpatient rehabilitation. The main question this study aims to answer is: Does a MiGo Tracker RTM program lead to significantly greater motor recovery at three-months post stroke than the usual care group. If successful, MiGo Tracker will lead to increased home exercise adherence and improved health outcomes for thousands of individuals following stroke.
Eligibility
Inclusion Criteria3
- Experienced one or more strokes less than one month (30 days) prior
- Upper Extremity Fugl-Meyer Score > 5 and <= 55 out of 66
- Absence of moderate to severe pain (<= 4 on the 10 point visual-analog pain scale)
Exclusion Criteria4
- age <18 years old
- Unable to follow 2-step commands
- Other neurological diagnosis (e.g. Parkinson's Disease)
- Other severe concurrent medical conditions that may prevent the participants from completing the 3-month study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Perform home exercise sessions while wearing MiGo Tracker device that logs exercise data.
Exercise following printed sheets or booklet
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06752707